KNSA 净利润历史(2017–2025)
Kiniksa Pharmaceuticals International, plc (KNSA) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
$59.0MFY2025 · FY2017 以来:-$64.9M → $59.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $59.0M | +236.6% |
| FY2024 | -$43.2M | -406.7% |
| FY2023 | $14.1M | -92.3% |
| FY2022 | $183.4M | +216.1% |
| FY2021 | -$157.9M | +2.1% |
| FY2020 | -$161.4M | +0.3% |
| FY2019 | -$161.9M | -56.8% |
| FY2018 | -$103.2M | -59.1% |
| FY2017 | -$64.9M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议